Onderneming Statera Biopharma, Inc. Nasdaq
Aandelen
STAB
US8575611046
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0007 USD | 0,00% | 0,00% | -99,98% |
Vakgebied
Aantal werknemers: 46
Verkoop per activiteit
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Toll-like Receptors
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +465,54% |
Verkoop per regio
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 81,2 % | 1 | 100,0 % | +596,47% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yakov Kogan
FOU | Founder | 50 | 05-06-03 |
Andrei V. Gudkov
FOU | Founder | 66 | 05-06-03 |
Michael Handley
CEO | Chief Executive Officer | 52 | 27-07-21 |
Christopher Zosh
DFI | Director of Finance/CFO | 48 | 01-06-14 |
Allie Lopez
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-20 |
James Mendolera
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-21 |
Chief Tech/Sci/R&D Officer | 63 | 27-07-21 | |
George Wagner
LAW | General Counsel | - | - |
Curt Dewitz
PRN | Corporate Officer/Principal | - | 01-03-20 |
Todd Headley
PRN | Corporate Officer/Principal | - | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John A. Kallassy
BRD | Director/Board Member | 59 | 02-09-22 |
Uday Saxena
BRD | Director/Board Member | 66 | 17-06-22 |
Michael Handley
CEO | Chief Executive Officer | 52 | 27-07-21 |
Director/Board Member | 68 | 24-02-22 | |
Director/Board Member | 59 | 17-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 71 416 038 | 71 416 038 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Statera Biopharma, Inc.
4333 Corbett Drive Suite 1082
80525, Fort Collins
+888 613 8802
http://www.staterabiopharma.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,46% | 54,04 mld. | |
+43,68% | 41,96 mld. | |
-1,31% | 41,92 mld. | |
-7,20% | 28,35 mld. | |
+12,51% | 26,35 mld. | |
-21,96% | 19 mld. | |
+7,17% | 13 mld. | |
+29,20% | 12,28 mld. | |
+25,53% | 12,19 mld. |
- Beurs
- Aandelen
- Koers STAB
- Koers STAB
- Onderneming Statera Biopharma, Inc.